by Bruce Sylvester: Among patients with metastatic hormone-sensitive prostate cancer, chemotherapy with docetaxel at the start of androgen deprivation therapy (ADT) has resulted in an increased survival of… read more.
by Bruce Sylvester: Treatment of diabetes with pioglitazone does not appear to be related to an increased risk of bladder cancer, researchers from an analysis including nearly 200,000… read more.
by Bruce Sylvester: Oral contraceptive use appears to provide long-term protection against endometrial cancer, researchers reported on August 4, 2015 in The Lancet Oncology.
by Bruce Sylvester: A retrospective analysis of data on more than 83,000 US veterans showed that men whose low testosterone was restored to normal achieved a reduced risk… read more.
by Bruce Sylvester: Corticosteroid therapy appears to benefit patients with pneumonia, researchers reported online on August 10, 2015 in the Annals of Internal Medicine.
by Bruce Sylvester: Aspirin use might slow progression of early emphysema, researchers reported on May 17, 2015 at American Thoracic Society International Conference.
by Bruce Sylvester: Seniors with migraines who smoke appear to be at an increased risk of stroke, researchers reported on July 22, 2015 in Neurology.
by Bruce Sylvester: Patients with depression or anxiety who were prescribed opioids for chronic lower back pain have achieved significantly less pain relief and were more likely to abuse their… read more.
by Bruce Sylvester: Researchers from two newly published studies patients report that patients with chronic hepatitis C virus (HCV) genotype 1 infection and with or without cirrhosis have… read more.
by Bruce Sylvester: Persons with high rates of diabetes-related complications appear to be more likely to develop dementia as they get older than persons with fewer diabetes-related complications, South… read more.
by Bruce Sylvester: Menopausal women having difficulty with time management, attention, organization, memory, and problem solving (also known as “executive functions”) appear to benefit from treatment with lisdexamfetamine,… read more.
by Bruce Sylvester: Treatment with tofacitinib, a drug for rheumatoid arthritis, has restored skin color in a patient suffering from vitiligo, researchers reported on June 24 in JAMA Dermatology.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
